319 related articles for article (PubMed ID: 19578751)
21. Classifying B-cell non-Hodgkin lymphoma by using MIB-1 proliferative index in fine-needle aspirates.
Ali AE; Morgen EK; Geddie WR; Boerner SL; Massey C; Bailey DJ; da Cunha Santos G
Cancer Cytopathol; 2010 Jun; 118(3):166-72. PubMed ID: 20544708
[TBL] [Abstract][Full Text] [Related]
22. [The utility of aspiration cytology for the distinction of aggressive and non-aggressive papillary carcinoma of the thyroid].
Caprara G; Collina G
Pathologica; 2007 Jun; 99(3):65-8. PubMed ID: 17987724
[TBL] [Abstract][Full Text] [Related]
23. [Thyroglobulin levels in needle lymph node cytology for the detection of papillary thyroid cancer recurrence].
Véliz J; Brantes S; Ramos C; Aguayo J; Cáceres E; Herrera M; Barber A; Barría M; Wohllk N
Rev Med Chil; 2008 Sep; 136(9):1107-12. PubMed ID: 19030653
[TBL] [Abstract][Full Text] [Related]
24. [Clinico-pathological study of thyroid carcinomas detected by mass screening].
Omata K; Iguchi K; Iida R; Ozawa T; Kusano T; Naoe S; Tanaka N
Gan No Rinsho; 1986 Jun; 32(7):740-8. PubMed ID: 3525885
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of MIB-1 immunoreactivity and nucleolar organizer regions in nonneoplastic and neoplastic thyroid lesions.
Lewy-Trenda I; Bieńkiewicz M
Pol J Pathol; 1999; 50(3):129-38. PubMed ID: 10624114
[TBL] [Abstract][Full Text] [Related]
26. Comparative topoisomerase IIa and ki 67 protein expression in papillary thyroid carcinoma based on tissue microarrays and image analysis.
Manaios L; Tsiambas E; Alevizaki M; Karameris A; Alexopoulou D; Lambropoulou S; Moreas H; Kravvaritis C; Fotiades PP; Goula K; Patsouris E; Athanassiou AE; Koutras D; Katsilambros N
J BUON; 2008; 13(4):537-41. PubMed ID: 19145676
[TBL] [Abstract][Full Text] [Related]
27. Papillary thyroid carcinoma with atypical histiocytoid cells on fine-needle aspiration.
Harshan M; Crapanzano JP; Aslan DL; Vazquez MF; Saqi A
Diagn Cytopathol; 2009 Apr; 37(4):244-50. PubMed ID: 19217032
[TBL] [Abstract][Full Text] [Related]
28. Transcription factor-mediated proliferation and apoptosis in benign and malignant thyroid lesions.
Letsas KP; Frangou-Lazaridis M; Skyrlas A; Tsatsoulis A; Malamou-Mitsi V
Pathol Int; 2005 Nov; 55(11):694-702. PubMed ID: 16271081
[TBL] [Abstract][Full Text] [Related]
29. Fine needle aspiration cytology of thyroid gland and histopathological correlation--revisited.
Mitra RB; Pathak S; Guha D; Patra SP; Chowdhury BR; Chowdhury S
J Indian Med Assoc; 2002 Jun; 100(6):382-4. PubMed ID: 12416671
[TBL] [Abstract][Full Text] [Related]
30. Proliferative activity of papillary carcinoma and benign papillary hyperplasia of thyroid follicular cells.
Dziecioł J; Lemancewicz D; Lebkowska U; Augustynowicz A; Dadan J; Klim B; Małdyk J
Folia Histochem Cytobiol; 2002; 40(2):201-2. PubMed ID: 12056645
[TBL] [Abstract][Full Text] [Related]
31. Assessment of proliferation index with MIB-1 as a prognostic factor in radiation therapy for cervical cancer.
Suzuki M; Tsukagoshi S; Saga Y; Ohwada M; Sato I
Gynecol Oncol; 2000 Nov; 79(2):300-4. PubMed ID: 11063661
[TBL] [Abstract][Full Text] [Related]
32. [The role of fine needle biopsy in diagnosis of thyroid cancer].
Sporny S
Wiad Lek; 2001; 54 Suppl 1():12-20. PubMed ID: 12182015
[TBL] [Abstract][Full Text] [Related]
33. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
34. Perioperative diagnosis of cystosarcoma phyllodes of the breast may be enhanced by MIB-1 index.
Ridgway PF; Jacklin RK; Ziprin P; Harbin L; Peck DH; Darzi AW; Rajan PB
J Surg Res; 2004 Nov; 122(1):83-8. PubMed ID: 15522319
[TBL] [Abstract][Full Text] [Related]
35. Cytologic features of mixed papillary carcinoma and chronic lymphocytic leukemia/small lymphocytic lymphoma of the thyroid gland.
Reid-Nicholson M; Moreira A; Ramalingam P
Diagn Cytopathol; 2008 Nov; 36(11):813-7. PubMed ID: 18831028
[TBL] [Abstract][Full Text] [Related]
36. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
37. Selenoenzymes, laboratory parameters, and trace elements in different types of thyroid tumor.
Zagrodzki P; Nicol F; Arthur JR; Słowiaczek M; Walas S; Mrowiec H; Wietecha-Posłuszny R
Biol Trace Elem Res; 2010 Apr; 134(1):25-40. PubMed ID: 19597722
[TBL] [Abstract][Full Text] [Related]
38. Pathology and cytologic features of thyroid neoplasms.
Malloy KM; Cunnane MF
Surg Oncol Clin N Am; 2008 Jan; 17(1):57-70, viii. PubMed ID: 18177800
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
Devaprasath A; Chacko G
Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
[TBL] [Abstract][Full Text] [Related]
40. [Follicular proliferation in aspiration cytology of thyroid nodules].
Corrales Hernández JJ; Gómez Sáez JM; Ferrer Socarrás JE; Soler Ramón J; Novials Sardá A
Med Clin (Barc); 1986 Apr; 86(14):579-81. PubMed ID: 3724264
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
